The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective.
作者信息
Deshmukh Kartik, Khanna Arjun
机构信息
Fuqua School of Business, Duke University, Durham, NC, USA.
Department of Pulmonary Medicine, Yashoda Hospital, Delhi, India.
出版信息
Tuberc Respir Dis (Seoul). 2021 Apr;84(2):167-170. doi: 10.4046/trd.2020.0151. Epub 2021 Feb 17.
Abstract
摘要
相似文献
1
The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective.
Tuberc Respir Dis (Seoul). 2021 Apr;84(2):167-170. doi: 10.4046/trd.2020.0151. Epub 2021 Feb 17.
2
Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease.
Curr Opin Pulm Med. 2008 Mar;14(2):115-21. doi: 10.1097/MCP.0b013e3282f45ffb.
3
β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
Ann Am Thorac Soc. 2018 May;15(5):608-614. doi: 10.1513/AnnalsATS.201708-626OC.
4
Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
BMJ. 2013 Mar 20;346:f1235. doi: 10.1136/bmj.f1235.
5
Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial.
Clin Trials. 2020 Aug;17(4):430-436. doi: 10.1177/1740774520920897. Epub 2020 May 22.
6
Cardiovascular risk, chronic obstructive pulmonary disease and pulmonary rehabilitation: Can we learn from cardiac rehabilitation?
Chron Respir Dis. 2016 Aug;13(3):286-94. doi: 10.1177/1479972316642367. Epub 2016 Apr 14.
7
Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation.
Drugs Aging. 2018 Dec;35(12):1099-1108. doi: 10.1007/s40266-018-0600-0.
8
Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study.
NPJ Prim Care Respir Med. 2017 May 18;27(1):36. doi: 10.1038/s41533-017-0034-x.
9
The Non-Communicable Disease Burden in Korea: Findings from the 2012 Korean Burden of Disease Study.
J Korean Med Sci. 2016 Nov;31 Suppl 2(Suppl 2):S158-S167. doi: 10.3346/jkms.2016.31.S2.S158.
10
Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978].
BMC Pulm Med. 2006 Feb 6;6:3. doi: 10.1186/1471-2466-6-3.
引用本文的文献
1
Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.
J Korean Med Sci. 2023 Oct 30;38(42):e344. doi: 10.3346/jkms.2023.38.e344.
本文引用的文献
1
Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases.
Tuberc Respir Dis (Seoul). 2021 Jan;84(1):35-45. doi: 10.4046/trd.2020.0088. Epub 2020 Oct 13.
2
One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry.
Int J Cardiol. 2020 Mar 1;302:47-52. doi: 10.1016/j.ijcard.2019.12.061. Epub 2020 Jan 2.
3
Assessing the evidence-practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics.
Eur J Heart Fail. 2020 Apr;22(4):646-660. doi: 10.1002/ejhf.1630. Epub 2019 Dec 9.
4
Characteristics, Management, and Outcomes of Patients Hospitalized for Heart Failure in China: The China PEACE Retrospective Heart Failure Study.
J Am Heart Assoc. 2019 Sep 3;8(17):e012884. doi: 10.1161/JAHA.119.012884. Epub 2019 Aug 21.
5
Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
J Cardiol. 2019 Jun;73(6):459-465. doi: 10.1016/j.jjcc.2019.01.005. Epub 2019 Feb 1.
6
Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan.
Int J Chron Obstruct Pulmon Dis. 2018 Sep 5;13:2759-2766. doi: 10.2147/COPD.S172679. eCollection 2018.
7
The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016.
Lancet Glob Health. 2018 Dec;6(12):e1363-e1374. doi: 10.1016/S2214-109X(18)30409-1. Epub 2018 Sep 12.
8
In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry.
J Card Fail. 2018 Dec;24(12):842-848. doi: 10.1016/j.cardfail.2018.05.007. Epub 2018 Jun 7.
9
Evaluation for airway obstruction in adult patients with stable ischemic heart disease.
Indian Heart J. 2018 Mar-Apr;70(2):266-271. doi: 10.1016/j.ihj.2017.08.003. Epub 2017 Aug 16.
10
Chronic obstructive pulmonary disease in China: a nationwide prevalence study.
Lancet Respir Med. 2018 Jun;6(6):421-430. doi: 10.1016/S2213-2600(18)30103-6. Epub 2018 Apr 9.
Zotero 插件